Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)
![Thumbnail](/xmlui/bitstream/handle/20.500.12511/10700/Sakin-Abdullah-2023.pdf.jpg?sequence=4&isAllowed=y)
View/ Open
Access
info:eu-repo/semantics/openAccessAttribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/Date
2023Author
Karacin, CengizÖksüzoğlu, Berna
Demirci, Ayşe
Keskinkılıç, Merve
Köse Baytemur, Naziyet
Yılmaz, Funda
Selvi, Oğuzhan
Hacıbekiroğlu, İlhan
Metadata
Show full item recordCitation
Karacin, C., Öksüzoğlu, B., Demirci, A., Keskinkılıç, M., Köse Baytemur, N., Yılmaz, F. ... Hacıbekiroğlu, İ. (2023). Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023). BMC Cancer, 23(1). https://dx.doi.org/10.1186/s12885-023-10662-3Abstract
Following publication of the original article [1], the authors reported an error in the author name of Enes Erul.